Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Your Immune System is Written in Your Genes



The study – which was published in the journal, Nature Communications – suggests that genes may play a bigger role in the development of the immune system than previously thought.

Share this!

January 6, 2017 | by Sarah Hand, M.Sc.

According to researchers at King’s College London, almost three quarters of a person’s immune traits are governed by their genetic information. The study – which was published in the journal, Nature Communications – suggests that genes may play a bigger role in the development of the immune system than previously thought.

The researchers used data on 497 pairs of adult female twins collected through the TwinsUK cohort. In analyzing 23,000 immune traits, the researchers found that complex immune responses – known as adaptive immune traits – which develop after a person is exposed to a specific antigen, are strongly influenced by genetics.

“Our genetic analysis resulted in some unusual findings, where adaptive immune responses, which are far more complex in nature, appear to be more influenced by variations in the genome than we had previously thought,” said Dr. Massimo Mangino, lead researcher from King's College London. “In contrast, variation in innate responses (the simple non-specific immune response) more often arose from environmental differences.”

The article also emphasizes the importance of environmental influences – such as diet, microbial exposure and infections – in childhood in developing the innate immune system. The findings could help inform future research in therapies for autoimmune diseases, including psoriasis and rheumatoid arthritis.

“Our results surprisingly showed how most immune responses are genetic, very personalized and finely tuned,” said Professor Tim Spector, Director of the TwinsUK Registry at King's College London. “What this means is that we are likely to respond in a very individualized way to an infection such as a virus - or an allergen such as a house dust mite causing asthma. This may have big implications for future personalized therapy.”

Keywords: Immune System, Autoimmune Disease, Genetics


Share this with your colleagues!

Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News

Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News

Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know


Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned

EDC and eSource: Combined for Better Data and Faster Insights

Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide

How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology

Copyright © 2016-2017 Honeycomb Worldwide Inc.